Novo Integrated Sciences - 15 Year Stock Price History | NVOS
Historical daily share price chart and data for Novo Integrated Sciences since 2011 adjusted for splits and dividends. The latest closing stock price for Novo Integrated Sciences as of June 09, 2026 is 0.01.
- The all-time high Novo Integrated Sciences stock closing price was 419.80 on February 17, 2012.
- The Novo Integrated Sciences 52-week high stock price is 0.06, which is 500% above the current share price.
- The Novo Integrated Sciences 52-week low stock price is 0.00, which is 100% below the current share price.
- The average Novo Integrated Sciences stock price for the last 52 weeks is 0.00.
| Novo Integrated Sciences Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2026 | 0.0049 | 0.0027 | 0.0290 | 0.0005 | 0.0090 | 233.33% |
| 2025 | 0.0163 | 0.0504 | 0.0980 | 0.0001 | 0.0027 | -94.80% |
| 2024 | 0.4715 | 0.7706 | 1.2400 | 0.0300 | 0.0519 | -93.68% |
| 2023 | 1.6397 | 1.8260 | 4.7000 | 0.7090 | 0.8210 | -59.17% |
| 2022 | 14.1651 | 14.5000 | 30.9000 | 1.9750 | 2.0110 | -85.64% |
| 2021 | 25.5761 | 43.0000 | 87.5000 | 12.9000 | 14.0000 | -66.67% |
| 2020 | 34.9409 | 40.0000 | 79.0000 | 14.4000 | 42.0000 | -6.67% |
| 2019 | 106.8409 | 200.0000 | 222.0000 | 30.0100 | 45.0000 | -77.50% |
| 2018 | 101.2134 | 50.9000 | 240.0000 | 27.0250 | 200.0000 | 286.10% |
| 2017 | 53.3101 | 21.0000 | 99.0000 | 20.2100 | 51.8000 | 115.83% |
| 2016 | 26.2765 | 3.0000 | 63.0000 | 3.0000 | 24.0000 | 700.00% |
| 2015 | 15.6768 | 38.8000 | 50.0000 | 3.0000 | 3.0000 | -92.27% |
| 2014 | 54.2444 | 29.8000 | 160.0000 | 23.2000 | 38.8000 | 51.56% |
| 2013 | 20.2698 | 24.0000 | 43.8000 | 5.4000 | 25.6000 | 6.67% |
| 2012 | 165.4216 | 180.0000 | 419.8000 | 22.8000 | 24.0000 | -65.71% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.000B | $0.013B |
| Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |